Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from MedX Health ( (TSE:MDX) ).
MedX Health Corp. has appointed Dr. Paul J. Matts, a renowned skin scientist and former R&D Vice President at Procter & Gamble, as a Strategic Advisor. Dr. Matts’ extensive experience in skin optics and sun protection will enhance MedX’s mission to advance early skin cancer detection and develop new skin assessment technologies. His appointment is expected to strengthen MedX’s scientific foundation and support the company’s goal of providing accessible skin cancer screening solutions.
More about MedX Health
MedX Health Corp., based in Ontario, Canada, is a leader in non-invasive skin assessment and teledermatology. The company offers proprietary SIAscopy® technology integrated into the DermSecure® platform, which allows for pain-free, accurate imaging of skin lesions for rapid dermatologist review. MedX’s products are approved for use in several countries including Canada, the U.S., Australia, and the European Union.
Average Trading Volume: 150,921
Technical Sentiment Signal: Sell
Current Market Cap: C$21.13M
For an in-depth examination of MDX stock, go to TipRanks’ Overview page.